Conferences

AIDS 2026

The 26th International AIDS Conference (AIDS 2026) took place in Rio de Janeiro, Brazil, and virtually from 26-31 July. aidsmap was an official scientific media partner for AIDS 2026.
Text saying: AIDS 2026 - 26th International AIDS Conference - 26-31 July - Rio de Janeiro, Brazil, and virtually. The AIDS 2026 and aidsmap logos are at the bottom and artwork of a red and green parrot in front of green palm leaves to the left.
Injectable & long-acting HIV treatment

Once-weekly islatravir / lenacapavir combination pill maintains HIV viral suppression

New
Economic & social inequality

Racism remains a central driver of global HIV epidemics

New
Liver disease

Lean people with HIV can still develop fatty liver disease

New
The search for a cure

A new class of drugs could sharpen the body’s immune response to HIV

New
Chemsex & recreational drug use

Chemsex is everywhere, but often invisible and unaddressed

New
Sexually transmitted infections prevention

DoxyPEP linked to reduction in syphilis and chlamydia among gay men in Australia

The search for a cure

Could leronlimab, a CCR5 blocker, be used to facilitate stem-cell transplant cures of HIV?

Low CD4 count

Returning to HIV care does not erase the effects of treatment interruption, studies show

Low CD4 count

Enhanced access to diagnostic screening improves care for advanced HIV

Weight gain & lipodystrophy

Alternative first-line HIV regimen limits excess weight gain

Global health initiatives

New US HIV agreements leave civil society and key populations on the sidelines

People who inject drugs

Fiji’s perfect HIV storm

The search for a cure

Two more people cured of HIV after stem cell transplants, offering more clues to long-term remission

Pregnancy and vertical transmission

Over 40% of Ugandan mothers whose infants acquired HIV were only diagnosed while breastfeeding

Finance & funding

PEPFAR cuts close key population services and accelerate decline in children's HIV treatment

PEP

Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP)

Injectable & long-acting HIV treatment

Islatravir plus ulonivirine shows promise for weekly oral HIV treatment

Starting treatment

Dolutegravir knocks down HIV faster than bictegravir

Injectable & long-acting HIV treatment

Long-acting injectable treatment superior to daily pills for adolescents in African trial

Economic & social inequality

Water insecurity nearly quadruples odds of poor HIV outcomes, while hunger and partner violence compound risk in East Africa

Injectable & long-acting PrEP

Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing

Injectable & long-acting PrEP

Nearly 200,000 lenacapavir shots given across Africa, but supply issues pose challenges

News about aidsmap

AIDS 2026 webinar: highlights from Rio de Janeiro

Videos

AIDS 2026: Once-weekly tablet for HIV treatment

31 July 2026

At the 26th International AIDS Conference (AIDS 2026), Dr Amy Colson of the Community Resource Initiative in Boston, US, spoke to aidsmap's Roger Pebody about a once-weekly oral islatravir / lenacapavir tablet for HIV treatment.

AIDS 2026: Racism and health

10 August 2026

At the 26th International AIDS Conference (AIDS 2026), Thiago Jerohan from Gestos, Recife, Brazil, spoke with aidsmap's Krishen Samuel about racism in Brazil. 

AIDS 2026: Roll-out of lencapavir PrEP

10 August 2026

At the 26th International AIDS Conference (AIDS 2026), Dr Barbara Mambo from the Ministry of Health, Kenya, talks about the roll-out of lenacapavir PrEP with aidsmap's Krishen Samuel.
 

AIDS 2026: Reducing weight gain when starting HIV treatment

11 August 2026

At the 26th International AIDS Conference (AIDS 2026), Dr Joana Woods from the University of the Witwatersrand, South Africa, talked with aidsmap's Roger Pebody about reducing weight gain when starting HIV treatment by using an alternative regimen.

AIDS 2026: The US government's bilateral health agreements

13 August 2026

At the 26th International AIDS Conference (AIDS 2026), Dr Jirair Ratevosian from Duke Global Health Institute, US, talks to aidsmap's Roger Pebody about the US government's bilateral health agreements. 

Conference bulletins

English

AIDS 2026: Weekly oral pill keeps HIV suppressed as well as daily treatment, 30 July 2026

(HTML)

AIDS 2026: Two more HIV cures after stem cell transplants offer new clues, 3 August 2026

(HTML)

AIDS 2026: Racism remains a central driver of global HIV epidemics, 6 August 2026

(HTML)